Home › Funds › Beau Ventures, LLc › BIIB
Beau Ventures, LLc position in BIIB
BIOGEN INC · Health Care
Beau Ventures, LLc reported holding 100,000 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$22.6M, representing 2.13% of its reported portfolio and ranking #8 among its reported holdings. Beau Ventures, LLc has disclosed BIIB holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Beau Ventures, LLc's BIIB position evolved
Beau Ventures, LLc first disclosed a stake in BIIB in Q4 2025 at 100,000 shares (US$17.6M). The position peaked in Q3 2026 at 100,000 shares, worth US$22.6M. Across 4 filings, Beau Ventures, LLc held the position steady without any share-count change. The most recent filing (Q3 2026) shows 100,000 shares valued at US$22.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 100.00K | $17.60M | New |
| Q1 2026 | 100.00K | $18.33M | Hold |
| Q2 2026 | 100.00K | $21.61M | Hold |
| Q3 2026 | 100.00K | $22.59M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.15M sh · $3.27B · Q2 2026
More on Beau Ventures, LLc
FAQ
How long has Beau Ventures, LLc held BIIB?
Beau Ventures, LLc has disclosed BIIB holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Beau Ventures, LLc's current position in BIIB?
As of Q3 2026, Beau Ventures, LLc holds 100.00K shares of BIIB (BIOGEN INC), valued at $22.59M, representing 2.13% of its reported portfolio and ranking #8.
Has Beau Ventures, LLc been buying or selling BIIB?
In the latest 13F filing (Q3 2026), Beau Ventures, LLc held unchanged its position in BIIB. The position peaked in Q3 2026 at 100.00K shares.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.